Acupoint stimulation for long COVID: A promising intervention: 穴位刺激治疗长新冠: 一种有前景的干预措施
BW Feng, PJ Rong - World Journal of Acupuncture-Moxibustion, 2023 - Elsevier
… is effective in treating the various phases of COVID-19. Previous … Several antiviral drugs,
such as remdesivir, molnupiravir, and … A systematic review and meta-analysis showed that …
such as remdesivir, molnupiravir, and … A systematic review and meta-analysis showed that …
[HTML][HTML] Acupoint stimulation for long COVID: A promising intervention: 穴位刺激治疗长新冠: 一种有前景的干预措施
BW Feng, PJ Rong - World Journal of Acupuncture-Moxibustion - ncbi.nlm.nih.gov
… is effective in treating the various phases of COVID-19. Previous … Several antiviral drugs,
such as remdesivir, molnupiravir, and … A systematic review and meta-analysis showed that …
such as remdesivir, molnupiravir, and … A systematic review and meta-analysis showed that …
[HTML][HTML] 从临床的角度回顾呼吸道传染病对COPD 病人影响的研究进展与思考
程晓雨， 冯恩志 - Advances in Clinical Medicine, 2023 - hanspub.org
… COVID-19 pandemic, and systematically elaborates on the characteristics of COPD patients
with COVID-19 and the treatment … /ritonavir)和莫诺拉韦(molnupiravir)均可有效减少未接种疫苗…
with COVID-19 and the treatment … /ritonavir)和莫诺拉韦(molnupiravir)均可有效减少未接种疫苗…
系统性红斑狼疮患者接种新型冠状病毒疫苗的建议及依据.
杨倩文， 朱昱彦， 何霞， 彭鲲， 吴越… - Evaluation & …, 2022 - search.ebscohost.com
… proposes recommendations of COVID-19 vaccine for SLE … 公司联 合开发的口服抗病毒药
Molnupiravir. 除常态化的防控措施 外,… and COVID-19 in 5 patients in Ecuador after prior treatment …
Molnupiravir. 除常态化的防控措施 外,… and COVID-19 in 5 patients in Ecuador after prior treatment …
[PDF][PDF] 奈玛特韦片/利托那韦片安全性病例回顾及文献综述
安鹏姣， 刘鑫， 张波 - 临床药物治疗杂志, 2023 - lcywzlzz.com
… systematic review of the safety of nirmatrelvir/ritonavir tablets in the treatment of severe corona
virus disease (COVID-19)… oral antiCOVID-19 agents nirmatrelvir-ritonavir and molnupiravir[…
virus disease (COVID-19)… oral antiCOVID-19 agents nirmatrelvir-ritonavir and molnupiravir[…
[PDF][PDF] 2022 年全球新冠肺炎疫苗和药物研究热点回眸
刘丽丽， 黄瑶庆， 高月红， 陆彩女， 王春丽， 毛艳艳 - 科技导报, 2023 - kjdb.org
… , and rationalized treatments that target COVID-19 clinical … COVID-19: Molnupiravir reduces
risk of hos⁃ pital admission … of COVID-19 vaccines and drugs based on literature and …
risk of hos⁃ pital admission … of COVID-19 vaccines and drugs based on literature and …
新型冠状病毒感染抗病毒药物引起肝损伤的发生机制.
曾雪， 李福青， 李清清， 王红 - Journal of Clinical Hepatology …, 2024 - search.ebscohost.com
… 本文对COVID-19抗病毒药物的种类及其 … Liver injury induced by COVID 19 treat⁃ ment -
what do we know?[J]. … -2 combating: From drugs repurposing to molnupiravir approval[J]. Drug …
what do we know?[J]. … -2 combating: From drugs repurposing to molnupiravir approval[J]. Drug …